These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20601039)

  • 1. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
    Greinix HT; Worel N; Knobler R
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
    Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
    Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
    Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
    Bisaccia E; Palangio M; Gonzalez J
    Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
    Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
    Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
    González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
    Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
    Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
    Kaloyannidis P; Mallouri D
    Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
    Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
    Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive extracorporeal photochemotherapy for severe acute hepatic graft-versus-host disease.
    Perotti C; Del Fante C; Viarengo G; Salvaneschi L
    Transfusion; 2004 Oct; 44(10):1531-2. PubMed ID: 15383028
    [No Abstract]   [Full Text] [Related]  

  • 13. Extracorporeal photopheresis in children with graft-versus-host disease.
    Chan KW
    J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
    J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
    Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
    Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Bykova TA; Kozlov AV; Stancheva NV; Semënova EV; Kulagina II; Bondarenko SN; Vavilov VN; Morozova EV; Zubarovskaia LS; Afanas'ev BV
    Ter Arkh; 2013; 85(8):60-8. PubMed ID: 24137966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
    Boluda B; Solana-Altabella A; Cano I; Acuña-Cruz E; Rodríguez-Veiga R; Ballesta-López O; Megías-Vericat JE; Martínez-Cuadrón D; Gómez I; Solves P; Lorenzo I; Piñana JL; Sanz J; Guerreiro M; Montoro Gómez J; Díaz-González A; Marco J; Blanco A; Sanz MÁ; Montesinos P
    J Clin Apher; 2021 Aug; 36(4):612-620. PubMed ID: 33964038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
    Greinix HT; Tanew A
    Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
    Greinix HT; Worel N; Just U; Knobler R
    Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photopheresis: clinical use so far.
    Sanford KW; Balogun RA
    J Clin Apher; 2012; 27(3):126-31. PubMed ID: 22467383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.